Abstract
The transplanted kidney is exposed to a wide range of injuries. These may afflict the kidney before, during, and after the surgical procedure. The trauma, shock, or morbidity that caused the death of the donor may affect the kidney even before the operation. In addition, the handling of the kidney, the extracorporeal perfusion, and the surgery itself may cause damage to the kidney during the operative and perioperative phase. After transplantation the kidney is also subjected to rejection and other deleterious conditions (summarized in Table 1). The resulting kidney damage is frequently associated with a generalized decrease in renal function characterized by oliguria or anuria of variable duration. Occasionally, however, despite this hostile environment, the glomerular filtration rate is relatively spared and the injury is predominantly tubulointerstitial (see Table 2). These tubular syndromes may cause profound changes in the acid-base balance and disturbances in electrolyte and mineral homeostasis, which may aggravate preexisting bone disease and lead to nephrocalcinosis or nephrolithiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Massry SG, Preuss HG, Maher JF, Schreiner GE: Renal tubular acidosis after cadaver kidney Homotransplantation. Am J Med 42:284–292, 1967.
Gyory AZ, Stewart JH, George CRP, Tiller DJ, Edwards KDG: Renal tubular acidosis, acidosis due to hyperkalemia hypercalcemia, disordered citrate metabolism and other tubular dysfunction following human renal transplantation. Q J Med 38:231–254, 1969.
Better OS, Chaimowitz C, Naveh Y, Stein A, Nahir AM, Barzilai A, Erlik D: Syndrome of incomplete renal tubular acidosis after cadaver kidney transplantation. Ann Intern Med 71:39–46, 1969.
Mookerjee B, Gault MH, Dossetor JB: Hypechloremic acidosis in early diagnosis of renal allograft rejection. Ann Intern Med 71:47–57, 1969.
Better OS, Chaimowitz C, Alroy GG, et al.: Spontaneous remission of the defect in urinary acidification after cadaver kidney homotransplantation. Lancet 1:110–112, 1970.
Wilson DR, Siddiqui AA: Renal tubular acidosis after kidney transplantation. Natural history and significance. Ann Intern Med 79:352–361, 1973.
Rubini ME, Agre KL, Mims MM, et al.: Curious tubular syndromes after homotransplantation (abstract). Clin Res 16:167, 1968.
Henderson LW, Nolph KD, Puschett JB, Goldberg M: Proximal tubular malfunction as a mechanism for diuresis after renal homotransplantation. N Engl J Med 278:467–473, 1968.
Liebau G, Muller R, Schad H, Edel HH: Proximale tubulare acidose bei nieretransplantierten patienten. Klin Wochenschr 48:624–629, 1970.
Briggs WA, Kominami N, Wilson RE, Merril JP: Kidney transplantation and Fanconi syndrome. N Engl J Med 286:25, 1972.
Vertuno LL, Preuss HG, Argy WP, Schreiner GE: Fanconi syndrome following homotransplantation. Arch Intern Med 133:302–305, 1974.
Vaziri ND, Nellands RE, Brueggmann RM, Barton CH, Martin DC: Renal tubular dysfunction in transplanted kidneys. Southern Med J 72:530–534, 1979.
Reubi FC, Montandon A: Renal glycosuria in renal homog-raft recipients. Klin Wochenschr 62:876–884, 1984.
Wrong O, Davies H: The excretion of acid in renal disease. Q J Med 28:259–313, 1959.
Morris RC Jr: Renal tubular acidosis: Mechanisms, classification and implications. N Engl J Med 281:1405–1413, 1968.
Halperin ML, Goldstein MB, Haig A, Johnson MD, Stinebaugh BJ: Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions. J Clin Invest 53:669–677, 1974.
Arruda JAL, Kurtzman NA: Mechanisms and classification of deranged distal urinary acidification. Am J Physiol 239:F515–F523, 1980.
Batlle DC, Sehy JT, Roseman MK, Arruda JAL, Kurtzman NA: Clinical and pathophysiologic spectrum of acquired distal-tubular acidosis. Kidney Int 20:389–396, 1981.
Helperin ML, Goldstein MB, Richardson RMA, Stinebaugh BJ: Distal renal tubular acidosis syndromes: A pathophysiological approach. Am J Nephrol 15:1–8, 1985.
Schambelan M, Stockgit J, Bigliery E: Isolated hypoaldos-teronism in adults: A renin-deficiency syndrome. N Engl J Med 287:573–578, 1972.
Perez GO, Oster JR, Vaamonde CA: Renal acidosis and renal potassium handling in selective hypoaldosteronism. Am J Med 57:809–816, 1974.
Hulter HW, Ilnicki LP, Harbottle JA, Sebastian A: Impaired renal H+ secretion and NH3 production in mineralo-corticoid deficient glucocorticoid replete dogs. Am J Physiol 232:F136-F146, 1977.
Ditella P, Sodhi B, McCreary J, Arruda JAL, Kurtzman NA: The mechanism of the metabolic acidosis of selective mineralocorticoid deficiency. Kidney Int 14:466–477, 1978.
Szylman P, Better OS, Chaimowitz C, Rosier A: Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism. N Engl J Med 294:361–365, 1976.
Battle DC, Mozes DF, Manaligod J, Arruda JAL, Kurtzman NA: The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation. Am J Med 70:786–796, 1981.
Tu WH, Shearn MA: Systemic lupus erythematosus and latent renal tubular dysfunction. Ann Intern Med 67:100–109, 1967.
Shioji R, Furuyama T, Onodera S, et al.: Sjogren syndrome and renal tubular acidosis. Am J Med 48:456–463, 1970.
DeOliviera HL: Excretion of ammonium in cases of acute tubular necrosis with acidosis and alkaline urine. Metabolism 2:36–46, 1953.
De Luna MB, Metcalfe-Gibson A, Wrong O: Urinary excretion of hydrogen ion in acute oliguric renal failure. Nephron 1:3–15, 1964.
Briggs JD, Kennedy AD, Young LN, Luke RG, Gary M: Renal function after acute tubular necrosis. Br Med J 33:513–516, 1967.
Winaver J, Agmon D, Harari R, Better OS: Impaired renal acidification following acute renal ischemia in the dog. Kidney Int 30:906–913, 1986.
Adu D, Turney J, Michael J, McMaster P: Hyperkalemia in cyclosporine-treated renal allograft recipients. Lancet 2:370–372, 1983.
Stahl PAK, Kantz L, Maier B, Schollmeyer P: Hyperchloremic metabolic acidosis with high serum potassium in renal transplant recipients: A cyclosporine A associated side effect. Clin Nephrol 25:245–248, 1986.
Batlle DC, Arruda JAL, Kurtzman NA: Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 304:373–380, 1981.
Muldowney FP, Carrol D, Donohoe JF, Freaney RF: Correction of renal bicarbonate wastage by parathyroidectomy. J Med 40:487–498, 1971.
Muldowney F, Donohoe J, Carrol D, Powell D, Freaney RF: Parathyroid acidosis in uremia. Q J Med 41:321–342, 1972.
Alfrey AC, Jenkins D, Groth CG, Schorr WS, Gecelter L, Ogden DA: Resolution of hyperparathyroidism, renal osteodystrophy and metastic calcification after renal homo-transplantation. N Engl J Med 279:1349–1356, 1968.
Butler HE Jr, Morgan JM, MacSmythe CM: Mercaptopurine and acquired tubular dysfunction in adult nephrosis. Arch Intern Med 116:853–856, 1965.
Gronert GA, Theye RA: Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43:89–99, 1975.
Cox M, Sterns RH, Singer I: The defense against hyperkalemia. The roles of insulin and aldosterone. N Engl J Med 299:525–532, 1978.
Field MJ, Giebisch GJ: Hormonal control of renal potassium excretion. Kidney Int 27:379–387, 1985.
Hudson JB, Chobanian AV, Relman AS: Hypoaldosteronism. A clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks. N Engl J Med 257:529–536, 1957.
DeFronzo RA, Goldberg M, Cook CR, Barker C, Grossman RA, Agus ZA: Investigations into the mechanisms of hyperkalemia following renal transplantation. Kidney Int 11:357–365, 1977.
Arnold JE, Healy JK: Hyperkalemia, hypertension and systemic acidosis without renal failure associated with a tubular defect in potassium excretion. Am J Med 47:461–472, 1969.
Gordon RD, Geddes RA, Pawsey CGK, O’Halloran MW: Hypertension and serve hyperkalemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Aust Ann Med 4:287–294, 1970.
Spitzer A, Edelman CM, Goldberg LD, Hanneman PH: Short stature, hyperkalemia and acidosis. A defect in renal transport of potassium. Kidney Int 3:251–257, 1973.
Weinstein SF, Allan DME, Mendosa SA: Hyperkalemia, acidosis and short stature associated with a defect in renal potassium secretion. J Pediat 85:355–358, 1974.
DeFronzo RA, Cooke CR, Goldberg M, Cow M, Myers AR, Agus ZS: Impaired renal tubular potassium secretion in systemic lupus erythematosus. Ann Intern Med 86:268–271, 1977.
DeFronzo RA, Taufield PA, Black H, McPhedran P, Cooke CR: Impaired tubular potassium secretion in sickle cell disease. Ann Intern Med 90:310–316, 1979.
Brautbar N, Levi J, Rosier A, Lietsdorf E, Djaldeti M, Epstein M, Kleeman CR: Familial hyperkalemia, hypertension and hyperreninemia with normal aldosterone levels. A tubular defect in potassium handling. Arch Intern Med 138:607–610, 1978.
Farfel Z, Iaina A, Rosenthal T, Waks U, Shibolet S, Gafni J: Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels. Possible hereditary cell membrane defect. Arch Intern Med 138:1828–1832, 1978.
Farfel Z, Iaina A, Levi J, Gafni J: Proximal tubular acidosis associated with familial normoaldosteronemic hyperpotassemia and hypertension. Arch Intern Med 138:1837–1840, 1978.
Finkelstein FO, Hayslett JP: Role of medullary structures in the functional adaptation of renal insufficiency. Kidney Int 6:419–425, 1974.
DeFronzo RA: Hyperkalemia and hyporeninemic hypo-aldosteronism. Kidney Int 17:118–134, 1980.
Perez G, Lespier L, Knowles R, Oster J, Vaamonde C: Hyporeninemia and hypoaldosteronism in diabetes mellitus. Arch Intern Med 137:852–855, 1977.
Oh MS, Carrol HJ, Clemmons JE, Vagnucci A, Levinson S, Whang E: A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease. Metabolism 23:1157–1166, 1974.
Pratt JH: Role of angiotensin II in potassium mediated stimulation of aldosterone secretion in the dog. J Clin Invest 70:667–672, 1982.
Roll D, Licht A, Rosier A, Durst AK, Kleeman CR, Czaczkes JW: Transient hypoaldosteronism after renal allotransplantation. Isr J Med Sci 15:29–34, 1979.
Wilson ID, Goetz FC: Selective hypoaldosteronism after prolonged heparin administration. Am J Med 36:635–640, 1964.
Uribarri J, Oh MS, Butt KMH, Carrol HJ: Pseudohypoal-dosteronism following kidney transplantation. Nephron 31:368–370, 1982.
Hamilton DV, Evans DB, Henderson RG et al.: Nephrotoxicity and metabolic acidosis in transplant patients on cyclosporin A. Proc Eur Dial Transpl Assoc 18:400–409, 1981.
Myers BD: Cyclosporine nephrotoxicity. Kidney Int 30:964–974, 1986.
Najarian JS, Strand M, Fryd DS, et al.: Comparison of cyclosporine versus azathioprine-antilymphocyte globulin in renal transplantation. Transplant Proc 15:2463–2468, 1983.
Foley RJ, Van Buren CT, Hammer R, Weinmann EJ: Cyclosoporine-associated hyperkalemia. Transplant Proc 15:2726–2729, 1983.
Bantle JP, Nath KA, Sutherland DER, Najarian JS, Ferris TF: Effect of cyclosporine on the renin-angiotensin aldosterone system and potassium excretion in renal transplant recipients. Arch Intern med 145:505–508, 1985.
Siegel H, Ryffel B, Petric R, Shoemaker P, Miller A, Donatsch P, Mihatsch M: Cyclosporine, the renin-angiotensin-aldosterone system, and renal adverse reactions. Transplant Proc 15:2719–2725, 1983.
Rosenbaum R, Hoffsten PE, Cryer P, Klahr S: Hyperkalemia after renal transplantation. Arch Intern Med 138:1270–1272, 1978.
Ogden DA, Porter KA, Terasaki PI, et al.: Chronic renal homograft function. Correlation with histology and lymphocyte antigen matching. Am J Med 43:837–845, 1967.
Gyory AZ, Edwards KDG: Renal tubular acidosis. A family with an autosomal dominant genetic defect in renal hydrogen ion transport, with proximal tubular and collecting duct dysfunction and increased metabolism of citrate and ammonia. Am J Med 45:43–62, 1968.
Gill JR, Bell HN, Bartter FC: Impaired conservation of sodium and potassium in renal tubular acidosis and its correction by buffer anions. Clin Sci 33:577–592, 1967.
David DS, Sakai S, Brennan BL, Riggio RA, Cheigh J, Stenzel KH, Rubin AL, Sherwood LM: Hypercalcemia after renal transplantation. N Engl J Med 289:398–401, 1973.
Krane RJ, Sang IC, Olson CA, et al.: Renal transplant ureteral obstruction simulating retroperitoneal fibrosis. JAMA 225:607–609, 1973.
Nagar D, Ferris FZ, Schacht RA: Obstructive polyuric renal failure following renal transplantation. Am J Med 60:702–706, 1976.
McPhaul JJ Jr, Mcintosh DA, Hammond WS, Park OK: Autonomous secondary (renal) parathyroid hyperplasia. N Engl J Med 271:1342–1345, 1964.
Hampers CL, Katz AI, Wilson RE, Merrill JP: Calcium metabolism and osteodystrophy after renal transplantation. Arch Intern Med 124:282–291, 1969.
Schwartz GH, David DS, Riggio RR, Saville PD, Whitsell JC, Stenzel KH, Rubin AL: Hypercalcemia after renal transplantation. Am J Med 49:42–51, 1970.
Geis WP, Popovtzer MM, Corman JL, Halgrimson CG, Groth CG, Starzl TE: Diagnosis and treatment of hyperparathyroidism after renal homotransplantation. Surg Gynecol Obstet 137:997–1010, 1973.
Pletka PG, Strom TB, Hampers CL, Griffiths H, Wilson RE, Bernstein DS, Sherwood LM, Merrill JP: Secondary hyperparathyroidism in human kidney transplant recipients. Nephron 17:371–381, 1976.
Chatterjee SN, Friedler RM, Berne TV, Oldham SB, Singer FR, Massry SG: Persistent hypercalcemia after successful renal transplantation. Nephron 17:1–7, 1976.
Christensen MS, Nielsen HE, Torring S: Hypercalcemia and parathyroid function after renal transplantation. Acta Med Scand 201:35–39, 1977.
Diethelm AG, Edwards RP, Whelchel JD: The natural history and surgical treatment of hypercalcemia before and after renal transplantation. Surg Gynecol Obst 154:481–490, 1982.
Conceicao SC, Wilkinson R, Feest TG, Owen JP, Dewar J, Kerr DNS: Hypercalcemia following renal transplantation: Causes and consequences. Clin Nephrol 16:235–244, 1981.
Cundy T, Kanis JA, Heynan G, Morris PJ, Oliver DO: Calcium metabolism and hyperparathyroidism after renal transplantation. Q J Med 52:67–78, 1983.
Sakhaee K, Brinker K, Helderman H, Bengfort JL, Nicar MJ, Hull AR, Pak CYC: Disturbances in mineral metabolism after successful renal transplantation. Miner Electrolyte Metab 11:167–172, 1985.
Ulmann A, Chkoff N, Lacour B: Disorders of calcium and phosphorus metabolism after successful kidney transplantation. In: J Hamburger, J Crosnier, JP Grunfeld, MH Maxwell, eds, Advances in Nephrology, Vol 12. Year Book Medical, Chicago, pp 331–340, 1983.
Parfitt AM: Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 8:92–112, 1982.
Bernheim J, Touraine JL, David L, Faivre JM, Traeger J: Evolution of secondary hyperparathyroidism after renal transplantation. Nephron 16:381–387, 1976.
Garabedian M, Silve C, Bentolila DL, Bourdeau A, Ulmann A, Nguyen TM, Lieberherr M, Broyer M, Balsan S: Changes in plasma 1,25 and 24,25-dihydroxyvitamin D after renal transplantation in children. Kidney Int 20:403–410, 1981.
Hornum I: Post transplant hypercalcemia due to mobilisation of metastic calcifications. Acta Med Scand 189:199–205, 1971.
Blohme I, Eriksson A: parathyroidectomy after renal transplantation. Scand J Urol Nephrol 42 (Suppl):134–136, 1977.
Garvin PJ, Castaneda M, Linderer R, Dickhans M: Management of hypercalcemic hyperparathyroidism after renal transplantation. Arch Surg 120:578–583, 1985.
Laflamme GH, Jowsey J: Bone and soft tissue changes with oral phosphate supplements. J Clin Invest 51:2834–2840, 1972.
Dominguez JM, Mautalen CA, Rodo JE, Barcat JA, Molins ME: Tertiary hyperparathyroidism diagnosed after renal homotransplantation. Am J Med 49:423–428, 1970.
Rosenberg JC, Arnstein AR, Ing TS, et al.: Calculi complicating renal transplant. Am J Surg 129:326–330, 1975.
Lattimer RG, Renning J, Stevens LE, Northway JD, Reemtsma K: Tertiary hyperparathyroidism following successful renal allografting. Am Surg 172:137–141, 1970.
Starzl TE, Groth CG, Putnam CW, et al.: Urologic complications in 216 human recipients of renal transplants. Ann Surg 172:1–22, 1970.
Walsh A: Nephrocalcinose sur rein greffe. J Urol Nephrol 75 (Suppl) 75:244, 1969.
Leapman SB, Vidne BA, Butt KMH, et al.: Nephrolithiasis and nephrocalcinosis after renal transplantation: A case report and review of the literature. J Urol 115:129–132, 1976.
Caralps A, Lloveras J, Masramon J, et al.: Urinary calculi after renal transplantation (letter). Lancet 1:544, 1977.
Cope O: The study of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 274:1174–1182, 1966.
Ward HN, Pabico RC, McKenna BA, Freeman RB: The renal handling of phosphate by renal transplant patients: Correlation with serum parathyroid hormone, cycle 3′5′ adenosine monophosphate urinary excretion, and allograft function. Adv Exp Med Biol 81:173–181, 1977.
Moorhead JF, Wills MR, Admed KY, Baillad RA, Varghese Z, Tatler GLV: Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet 1:649–697, 1974.
Graf H, Kovarik J, Stummvol HK, Wolf A, Pinggera WF: Handling of phosphate by the transplanted kidney. Proc Eur Dial Transpl Assoc 16:624–629, 1979.
Olgaard K, Madsen S, Lund BJ, Sorensen OH: Pathogenesis of hypophosphatemia in kidney necrograft recipient: A controlled trial. Adv Exp Med Biol 128;255–261, 1980.
Rosenbaum RW, Hruska KA, Korkor A, Anderson C, Slatopolsky E: Decreased phosphate reabsorption after renal transplantation: Evidence for a mechanism independent of calcium and parathyroid hormone. Kidney Int 19:568–578, 1981.
Ingbar S, Kon E, Burnett C, Relman A, Burrows B, Sisson J: The effect of cortisone on the renal tubular transport of uric acid, phosphorus, and electrolytes in patients with normal renal and adrenal function. J Lab Clin Med 38:533–541, 1951.
Parfitt AM, Kleerekoper M, Cruz C: Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: Implications for the pathogenesis of hyperparathyroidism in chronic renal failure. Miner Electrolyte Metab 12:356–362, 1986.
Gold LW, Massry SG, Arieff AL, Coburn JW: Renal bicarbonate wasting during phosphate depletion. A possible cause of altered acid-base homeostasis in hyperparathyroidism. J Clin Invest 52:2556–2562, 1973.
Gurland HJ, Brunner FP, Ghanther C, et al.: Combined report on regular dialysis and transplantation in Europe. VI 1975. In: BHB Robinson, P Vereerstraeten, JE Hawkins, eds, Dialysis, Transplantation, Nephrology. Proceedings of the European Dialysis and Transplantation Association, Hamburg, Germany. Pitman Press, Bath, England, pp 22–25, 1975.
Levin M, Franklin EC, Frangione B, Pras M: The amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 51: 2773–2776, 1972.
Sohar E, Gafni J, Pras M, Heller H: Familial Mediterranean fever: A survey of 470 cases and review of the literature. Am J Med 43:227–253, 1967.
Gafni J, Ravid M, Sohar E: The role of amyloidosis in familial Mediterranean fever: A population study. Isr J Med Sci 4:995–999, 1968.
Ben Ari J, Zlotnik M, Oren A, Berlyne GM: Dialysis in renal failure caused by amyloidosis of familial Mediterranean fever. Arch Intern Med 136:449–451, 1976.
Jacob ET, Bar-Nathan N, Shapira Z, Gafni J: Renal transplantation in the amyloidosis of familial Mediterranean fever. Arch Intern Med 139:1135–1138, 1979.
Better OS, Tuma S, Barzilai D: Diminished adrenocortical function reserve in patients with familial Mediterranean fever and renal amyloidosis. In: Frontiers in Internal Medicine. Karger, Basel, p 339, 1974.
Jones NF: Renal amyloidosis: Pathogenesis and therapy. Clin Nephrol 6:459–464, 1976.
Kennedy CL, Castro LE: Transplantation for renal amy-loidosise. Transplantation 24:382–385, 1977.
Jones MB, Adams JM, Passer JA: Amyloidosis in renal allograft in familial Mediterranean fever (letter). Ann Intern Med 87:579–580, 1977.
Benson MD, Skinner M, Cohen AS: Amyloid deposition in renal transplant in familial Mediterranean fever. Ann Intern Med 87:31–34, 1977.
Jacob ET, Siegal B, Bar-Nathan N, Gafni J: Improving outlook for renal transplantation in amyloid nephropathy. Transplant Proc 14:41–45, 1982.
Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 291:934–937, 1974.
Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J: Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 314:1001–1005, 1986.
Pollini J, Guttmann RD, Beaudoin JB, Morehouse DD, Klassen J, Knacck J: Late hypertension following renal allotransplantation. Clin Nephrol 11:202–212, 1979.
Ypersele de Strihou CV, Vereestraeten P, Wauthier M, et al.: Prevalence, etiology and treatment of late post transplant hypertension. In: J Hamburger, J Corsnier, JP Grunfeld, MH Maxwell, eds, Advances in Nephrology, Vol 12. Yearbook Medical, Chicago, pp 41–60, 1983.
Waltzer WC, Turner S, Frohnert P, Rapaport FT: Etiology and pathogenesis of hypertension following renal transplantation. Nephron 42:102–109, 1986.
Cohen S: Hypertension in renal transplant recipients: Role of bilateral nephrectomy. Br Med J 3:78–81, 1973.
McHugh MI, Tanboga H, Mareen R, Liano F, Robson V, Wilkinson R: Hypertension following renal transplantation. The role of the host’s kidneys. Q J Med 196:395–403, 1980.
Linas SL, Miller PD, McDonald KM, Stables DP, Katz P, Weil R, Schrier R: Role of the renin-angiotensin system in post transplantation hypertension in patients with multiple kidneys. N Engl J Med 298:1440–1444, 1978.
Curtis JJ, Luke RG, Jones P, Diethelm AG, Welchel JD: Hypertension after successful renal transplantation. Am J Med 79:193–200, 1985.
Curtis JJ, Luke RG, Diethelm AG, Whelchel JD, Jones P: Benefits of removal of native kidneys in hypertension after renal transplantation. Lancet 2:739–742, 1985.
Bennett WM, McDonald WJ, Lawson RK, Porter GA: Post tranplant hypertension: Studies of cortical blood flow and the renal pressor system. Kidney Int 6:99–108, 1974.
West TH, Turcotte JG, Vander A: Plasma renin activity, sodium balance and hypertension in a group of renal transplant recipients. J Lab Clin Med 73:564–573, 1969.
Bachy C, Alexandre GPJ, Ypersele de Strihou CV: Hypertension after renal transplantation. Br Med J 2:1287–1289, 1976.
Lacombe M: Arterial stenosis complicating renal allotransplantation in man. Ann Surg 181:283–288, 1975.
Lindsey ES, Garbus SB, Golladay ES, et al.: Hypertension due to renal artery stenosis in transplanted kidneys. Ann Surg 181:604–610, 1975.
Lindfors O, Lassonon L, Fyhrquist F, Kock B, Lindstrom B: Renal artery stenosis in hypertensive renal transplant recipients. J Urol 118:240–243, 1977.
Popovtzer MM, Pinnggera W, Katz FH, Corman JL, Robinette J, Lonois B, Halgrimson CG, Starzel TE: Variations in arterial blood pressure after kidney transplantation. Circulation 47:1297–1305, 1973.
Weidmann P, Massry SG, Coburn JW, Maxwell MH, Atleson J, Kleeman CR: Blood pressure effects of acute hyper-caclcemia — studies in patients with chronic renal failure. Ann Intern Med 76:741–745, 1972.
Earll JM, Kurtzman NA, Moser RH: Hypercalcemia and hypertension. Ann Intern Med 64:378–381, 1966.
Posborg PV, Steen OT, Kessmeyer-Neilsen F: Late failure of human renal transplant. Medicine 54:45–71, 1975.
McDonald FD, Brennan LA, Turcotte JG: Severe hypertension and elevated plasma renin activity following transplanation of “hepatorenal donor” kidneys into anephric recipients. Am J Med 54:39–43, 1973.
Whelton PK, Russel RP, Harrington DP, Williams GM, Walker WG: Hypertension following renal transplantation: Causative factors and therapeutic implications. JAMA 241:1128–1131, 1979.
Beckerhoff R, Uhlschmid G, Vetter W, Armbuster H, Siegenthaler W: Plasma renin and aldosterone after renal transplantation. Kidney Int 5:39–46, 1974.
Zawada ET, Maxwell MH, Marks LS: The diagnostic and therapeutic uses of saralasin in renal transplant hypertension. J Urol 123:148–152, 1980.
Schramek A, Adler O, Hashmonai M, Better OS, Turna S, Barzilai A: Hypertensive crisis, erythrocytosis and uremia due to renal-artery stenosis of kidney transplants. Lancet 1:70–71, 1975.
Bacon BR, Rothman SA, Ricanati ES, Rashad FA: Renal artery stenosis with erythrocytosis after renal transplantation. Arch Intern Med 140:1206–1211, 1980.
Curtis JJ, Luke RG, Whelchel JD, Diethelm AG, Jones P, Dustan HP: Inhibition of angiotensin converting enzyme in renal transplant recipients with hypertension. N Engl J Med 308:377–381, 1983.
Waltzer WC, Anaise D, Arbeit L, Weinstein S, Rapaport FT: Usefulness of Captopril in the management of hypertension after renal transplantation. Transplant Proc 16:1372–1374, 1984.
Reilly OT, Wood RFM, Watkin EM: Attempted balloon catheter dilation of transplant renal artery stenosis and subsequent operative correction. Transplantation 32:444–445, 1981.
Nies BA, Cohn R, Schrier SL: Erythemia after renal transplantation. N Engl J Med 273:785–788, 1965.
Westerman MP, Jenkins JL, Dekker A, Kreutner A, Fisher B: Significance of erythrocytosis and increased erythropoietin secretion after renal transplantation. Lancet 2:755–757, 1967.
Wu KK, Gibson TP, Freeman RM, Bonney WW, Fried W, DeGowin RL: Erythrocytosis after renal transplantation. Its occurrence in two recipients of kidneys from the same cadaver donor. Arch Intern Med 132:898–902, 1973.
Nellans R, Otis P, Martin DC: Polycythemia following renal transplantation. Urology 6:158–163, 1975.
Wickre CG, Norman DJ, Bennison A, Barry JM, Bennett WM: Post renal transplant erythrocytosis: A review of 53 patients. Kidney Int 23:731–737, 1983.
Obermiller LE, Tzamaloukas AH, Avasthi PS, Halpern JA, Sterling WA: Decreased plasma volume in post transplant erythrocytosis. Clin Nephrol 23:213–217, 1985.
Dagher FJ, Ramos E, Erslev AJ, Alongi SV, Karmi SA, Caro J: Are the native kidneys responsible for erythrocytosis in renal allorecipients? Transplantation 28:496–498, 1979.
Thevenod F, Radke HW, Grutzmacher P, Vincent E, Koch KM, Schoeppe W, Fassbinder W: Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. Kidney Int 24:227–232, 1983.
Meyrier A, Simon P, Boffa G, Brissot P: Uremia and the liver: The liver and erythropoiesis in chronic renal failure. Nephron 29:3–6, 1981.
Barbour GL: Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 139:889–891, 1979.
Hammond D, Winnick S: Paraneoplastic erythrocytosis and ectopic erythropoietins. Ann NY Acad Sci 230:219–227, 1974.
Anagnostou A, Baranowski R, Pillary VK, Kurtzman N, Vercellotti G, Fried W: Effect of renin on extrarenal erythropoietin production. J Lab Clin Med 88:707–715, 1976.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Winaver, J., Green, J., Better, O.S. (1991). Tubular and Metabolic Dysfunction Following Kidney Transplantation. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_58
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_58
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive